Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

8 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Notifiable Agents according to RKI - Erregerliste RKI

- 20/09/21 - 1 modulo, 1 ItemGroup, 1 elemento, 2 lingue
ItemGroup: Notifiable Agent
Notifiable Agents according to RKI. ODM created by Prof. Dr. Martin Dugas. Semantic annotation created by Prof. Dr. Sylvia Thun and Prof. Dr. Martin Digas

Infectious Disease Markers NHLBI - Lab Infectious Disease Markers ISO Date Format Version 1 2004

- 20/09/21 - 1 modulo, 14 itemgroups, 48 elementi, 1 linguaggio
Itemgroups: Registry Use Only, Identification Data, HSCT Type , Product Type, Source Information, Hepatitis B Virus, Hepatitis C Virus, Human T-Lymphotropic Virus, Human Immunodeficiency Virus, Syphilis, Cytomegalovirus, West Nile Virus, Infectious Disease Marker, Author Information
Infectious Disease Markers Uses The ISO Date Format Version 1 Lab - 2004 - Infectious Disease Markers ISO Date Format Version 1 - 2884169v1.0 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6A861230-7A94-FE96-E040-BB89AD434611

Lab - 2004 - Infectious Disease Markers - 2630454v6.0 - 2004 - Infectious Disease Markers

- 20/09/21 - 1 modulo, 17 itemgroups, 48 elementi, 1 linguaggio
Itemgroups: Registry Use Only, Identification Data Part 1 of 4, Identification Data Part 2 of 4, Identification Data Part 3 of 4, Identification Data Part 4 of 4 , HSCT Type , Product Type, Source Information, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) , Human T-Lymphotropic Virus , Human Immunodeficiency Virus (HIV) , Syphilis , Cytomegalovirus (CMV), West Nile Virus (WNV) , Other Infectious Disease Marker, Author Information
Infectious Disease Markers Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=62093463-23EF-B53C-E040-BB89AD434539

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons GENITAL HERPES RECURRENCES NCT00079911

- 03/08/17 - 1 modulo, 2 itemgroups, 12 elementi, 1 linguaggio
Itemgroups: Study administration, GENITAL HERPES RECURRENCES
NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection

Study SHIP-TREND_TREND1_PIA - t1.signinfect2

- 26/10/24 - 26 moduli, 1 ItemGroup, 6 elementi, 2 lingue
ItemGroup: t1.signinfect2
SHIP Study https://doi.org/10.1093/ije/dyac034

t1.pia_sf12

1 ItemGroup 12 elementi

t1.symptomresp1

1 ItemGroup 32 elementi

t1.allergyresp

1 ItemGroup 24 elementi

t1.pia_solidar

1 ItemGroup 7 elementi

t1.piacontact

1 ItemGroup 37 elementi

t1.pia_impact

1 ItemGroup 75 elementi

GSK TWINRIX™ Hepatitis A and B Vaccine: Persistence of Immune Response in 0,6 Month vs. 0,1,6 Month Schedule NCT00197119 - Longterm Follow-up Visit 13

- 17/09/21 - 1 modulo, 6 itemgroups, 23 elementi, 1 linguaggio
Itemgroups: Informed consent, Demographics, Laboratory Tests, Follow-up studies, Investigator signature, Tracking Document Reason for non participation
GSK TWINRIX™ Hepatitis A and B Vaccine: Persistence of Immune Response in 0,6 Month vs. 0,1,6 Month Schedule NCT00197119 - Longterm Follow-up VISIT 13 - YEAR 8 - 96 MONTHS + 2 MONTHS Study ID: 100566 Clinical Study ID: 100566 Study Title: Evaluate Persistence of Immune Response of GSK Biologicals’ TWINRIX™ Vaccine Administered According to 0,6 Month Schedule Versus TWINRIX™ JUNIOR Administered According to 0,1,6 Month Schedule, in Subjects Aged 12-15 years at Time of First Vaccine Dose Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00197119 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: BIO HAB; Twinrix Study Indication: Hepatitis A; Hepatitis B

HIV HPV vaccine NCT00513526 AMC-052 - High Resolution Anoscopy

- 19/07/17 - 1 modulo, 2 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Digital rectal exam, Anoscopy
Infection NCT00513526 On-Study - AMC-052 High Resolution Anoscopy (HRA) Form - 2676571v1.0 AMC-052 High Resolution Anoscopy (HRA) Form Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3950FE87-444E-42CA-E044-0003BA3F9857

Anforderung MS ENDO Sub MS University Hospital Muenster (UKM) Subform

- 09/11/16 - 1 modulo, 1 ItemGroup, 9 elementi, 1 linguaggio
ItemGroup: General Information
Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: AF MS Sozdienst LSTM Sub.

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial